Allergen Profile With Total IgE, Respiratory−Area 8
Use
Detect possible allergic responses to various substances in the environment (see Test Includes) and evaluate for hay fever, asthma, atopic eczema, and respiratory allergy. The quantitative allergen-specific IgE test is indicated (1) to determine whether an individual has elevated allergen-specific IgE antibodies; (2) if specific allergic sensitivity is needed to allow immunotherapy to be initiated; (3) when testing individuals for agents that may potentially cause anaphylaxis; (4) when evaluating individuals who are taking medication (eg, long-acting antihistamines) that may interfere with other testing modalities (eg, skin testing); (5) if immunotherapy or other therapeutic measures based on skin testing results have not led to a satisfactory remission of symptoms; (6) when an individual is unresponsive to medical management where identification of offending allergens may be beneficial.
Special Instructions
Not provided.
Limitations
Not provided.
Methodology
Thermo Fisher ImmunoCAP®
Biomarkers
LOINC Codes
- 49017-7
- 19113-0
- 6096-2
- 6095-4
- 6833-8
- 6098-8
- 6041-8
- 6265-3
- 6078-0
- 6212-5
- 6075-6
- 6025-1
- 6020-2
- 7155-5
- 6178-8
- 6189-5
- 6109-3
- 15285-0
- 6090-5
- 6278-6
- 33982-0
- 6209-1
- 6281-0
- 6085-5
- 6234-9
- 7604-2
- 6232-3
- 6181-2
Result Turnaround Time
3-4 days
Related Documents
For more information, please review the documents below
Specimen
Unknown
Volume
Not provided
Minimum Volume
Not provided
Causes for Rejection
Inadequate labeling; gross hemolysis
